Advanced Dual-Action Glycemic Control

BENOGLIP-M Tablets by MK Healthcare represent a high-performance therapeutic approach to managing Type 2 Diabetes Mellitus. This formulation combines two powerful antidiabetic agents: Teneligliptin (20mg) and Metformin Hydrochloride (500mg). While Metformin works by reducing glucose production in the liver and improving insulin sensitivity, Teneligliptin?a DPP-4 inhibitor?increases the release of insulin from the pancreas in response to meals. This dual-action synergy ensures comprehensive 24-hour blood sugar management, helping patients achieve their target HbA1c levels more effectively than mono-therapy.

Targeted Post-Prandial and Fasting Glucose Management

The clinical efficacy of BENOGLIP-M lies in its ability to address both fasting and post-meal (post-prandial) glucose spikes. Teneligliptin slows the breakdown of incretin hormones, which naturally regulate blood sugar levels after eating. Meanwhile, the sustained action of Metformin ensures that baseline glucose levels remain stable throughout the day. By targeting these two distinct metabolic pathways, BENOGLIP-M provides a balanced glycemic profile, reducing the risk of sudden hypoglycemia while protecting the body from the long-term complications of chronic hyperglycemia.

Cardiovascular Safety and Weight Neutrality

Beyond blood sugar control, BENOGLIP-M Tablets offer significant advantages for long-term health. Unlike some older classes of antidiabetic drugs, the combination of Teneligliptin and Metformin is generally considered weight-neutral, making it an excellent choice for patients concerned about weight gain. Furthermore, clinical studies have highlighted the favorable cardiovascular safety profile of DPP-4 inhibitors. By maintaining stable glucose levels without putting undue stress on the heart, BENOGLIP-M serves as a reliable cornerstone for patients looking to manage their diabetes while prioritizing their overall metabolic and cardiovascular well-being.

Pharmaceutical Excellence and Quality Assurance

Manufactured by MK Healthcare, an ISO-GMP certified leader in the pharmaceutical sector, BENOGLIP-M is produced under the most stringent quality control protocols to ensure maximum safety and therapeutic purity. The tablets are protected in premium ALU-ALU blister packaging, which provides a superior barrier against moisture and environmental degradation, ensuring the stability of the active ingredients. As a prescription medication, it offers a professional-grade solution for the proactive management of diabetes. Trust MK Healthcare for a science-backed formula that empowers you to lead a healthier, more controlled life.